New therapy for Small Cell Lung Cancer... - Lung Cancer Support

Lung Cancer Support

3,990 members2,163 posts

New therapy for Small Cell Lung Cancer patients to lower chance of getting neutropenia: FDA Approval of COSELA (trilaciclib)

Miranda_GO2 profile image
Miranda_GO2Partner
4 Replies

On February 12th, 2021, the Food and Drug Administration (FDA) approved Cosela (trilaciclib) for patients with extensive stage small cell lung cancer (ES-SCLC) (cancer which has spread outside of the lung) to help reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy. The FDA based their approval off of three different clinical trials which showed that patients receiving Cosela along with their chemotherapy had a lower chance of getting neutropenia (low white blood cell count) and those that did experience neutropenia had it for a shorter period of time.

Cosela is a first in class drug for ES-SCLC patients meant to protect bone marrow health and increase quality of life.

“Quite often, people diagnosed with extensive-stage small cell lung cancer rely on chemotherapy to not only extend their lives, but also to acutely alleviate their symptoms… Unfortunately, the vast majority will experience chemotherapy-induced side effects, resulting in dose delays and reductions, and increased utilization of healthcare services. We are thrilled to see new advancements that can help improve the lives of those living with small cell lung cancer.” -Bonnie J. Addario, Co-Founder and Board Chair, GO2 Foundation for Lung Cancer

Written by
Miranda_GO2 profile image
Miranda_GO2
Partner
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Denzie profile image
DenzieModeratorVolunteer

As someone who required 4 transfusions during the course of my treatment due to low neutrophils I’m glad to see this is an option.

Is this approved for NSCLC yet? It would have saved me from some of the worst fatigue.

Miranda_GO2 profile image
Miranda_GO2Partner in reply to Denzie

Great question, Denzie. Right now Cosela is only approved for SCLC, not NSCLC. The way the drug works, it should be particularly effective in SCLC because it works better when there are mutations of the Rb gene, which is common in SCLC.

Jando2021 profile image
Jando2021

My partner has been using Life Mel honey to help with white blood cells. This has been recommended by Dr Chris on TV and it has helped my partner.

Denzie profile image
DenzieModeratorVolunteer in reply to Jando2021

I’m glad it worked for your friend. I looked up the clinical trial the claims are based on and they closed it in 2009 without releasing their results or publishing their data. When that happens it’s often because they didn’t meet their end goals or the results did not substantiate their claims.

That said, honey does help soothe radiation caused esophagitis. But at $50-65 US for 4 ounces Life Mel is more than most can afford. A typical bottle of honey is about $4 US.

Always talk to your doctor or a nutritionist about using supplemental treatments because some will interfere with treatment.

You may also like...

First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)

s-and-databases/fda-approves-osimertinib-adjuvant-therapy-non-small-cell-lung-cancer-egfr-mutations

Opdivo and Yervoy combination approved for Non-small cell lung cancer

advanced non-small cell lung cancer (NSCLC) with a PD-L1 level equal to or greater than 1% for...

FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression

here:...

Extrapulmonary small cell cancer

same as for small cell lung cancer (SCLC). She is currently receiving 4 cycles of chemotherapy...

Devastated! my Non-Small Cell Lung Cancer Transformed into Small Cell Lung Cancer

July confirmed that my Non-Small Cell has transformed to Small Cell Lung Cancer. Just completed my...